Review of mechanism of action studies of the nitrosoureas.

Suppr

超能文献

作者信息

Bono V H

出版信息

Cancer Treat Rep. 1976 Jun;60(6):699-702.

PMID:182364

Abstract

摘要

相似文献

Review of mechanism of action studies of the nitrosoureas.

Cancer Treat Rep. 1976 Jun;60(6):699-702.

Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent.新型亚硝基脲类抗肿瘤药物氯脲霉素（Nsc - 178248）的药理学

Cancer Treat Rep. 1976 Jun;60(6):801-5.

Differential sensitivity of colony-forming cells of hemopoietic tissue, Lewis lung carcinoma, and B16 melanoma to three nitrosoureas.造血组织、Lewis肺癌和B16黑色素瘤的集落形成细胞对三种亚硝基脲的敏感性差异

Cancer Chemother Rep. 1975 Sep-Oct;59(5):929-33.

Effects of structure and chemical activity on the ability of nitrosoureas to inhibit DNA repair.结构和化学活性对亚硝基脲抑制DNA修复能力的影响。

Cancer Res. 1980 Jan;40(1):50-5.

Measurements of DNA damage in Chinese hamster cells treated with equitoxic and equimutagenic doses of nitrosoureas.用等毒性和等诱变剂量的亚硝基脲处理中国仓鼠细胞后DNA损伤的测量

Cancer Res. 1978 Oct;38(10):3379-84.

Biological and biochemical properties of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea (NSC D 254157), a nitrosourea with reduced bone marrow toxicity.

Cancer Res. 1977 Mar;37(3):783-7.

DNA damage and repair in mouse leukemia L1210 cells treated with nitrogen mustard, 1,3-bis(2-chloroethyl)-1-nitrosourea, and other nitrosoureas.用氮芥、1,3-双（2-氯乙基）-1-亚硝基脲及其他亚硝基脲处理的小鼠白血病L1210细胞中的DNA损伤与修复

Cancer Res. 1977 Jul;37(7 Pt 1):2114-22.

Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.氨甲酰化基团的化学结构及其与双功能烷基化和氨甲酰化亚硝基脲的骨髓毒性和抗胶质瘤活性的关系。

Cancer Res. 1985 Sep;45(9):4185-91.

[Antitumor activity of a new nitrosourea, MCNU, on a cellular morphological basis evaluated by a new in vitro antitumor sensitivity assay].

Gan To Kagaku Ryoho. 1984 Dec;11(12 Pt 1):2550-6.

Inhibition and recovery of DNA synthesis in host tissues and sensitive and resistant B16 melanoma after 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea, a predictor of therapeutic efficacy.1-（2-氯乙基）-3-（反式-4-甲基环己基）-1-亚硝基脲作用后宿主组织以及敏感和耐药B16黑色素瘤中DNA合成的抑制与恢复，一种治疗效果的预测指标

Cancer Res. 1975 Sep;35(9):2420-5.

引用本文的文献

Current status and patent prospective of animal models in diabetic research.糖尿病研究中动物模型的现状与专利前景

Adv Biomed Res. 2015 May 29;4:117. doi: 10.4103/2277-9175.157847. eCollection 2015.

Description of the sphingolipid content and subspecies in the diabetic cornea.糖尿病角膜中鞘脂含量及亚类的描述。

Curr Eye Res. 2015;40(12):1204-10. doi: 10.3109/02713683.2014.990984. Epub 2014 Nov 26.

Enhanced antitumor activity and reduced toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea administered in lipid microspheres to tumor-bearing mice.脂质微球包裹的1,3-双(2-氯乙基)-1-亚硝基脲对荷瘤小鼠的抗肿瘤活性增强及毒性降低。

Jpn J Cancer Res. 1993 Oct;84(10):1078-85. doi: 10.1111/j.1349-7006.1993.tb02804.x.

Clinical pharmacokinetics of commonly used anticancer drugs.常用抗癌药物的临床药代动力学

Clin Pharmacokinet. 1983 May-Jun;8(3):202-32. doi: 10.2165/00003088-198308030-00002.

CGP 6809, a sugar-containing nitrosourea derivative: pharmacological and physicochemical properties.

Cancer Chemother Pharmacol. 1989;23(6):341-7. doi: 10.1007/BF00435833.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验